Lv1
30 积分 2022-01-25 加入
Bispecific and multispecific antibodies in oncology: opportunities and challenges
7天前
已完结
Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer
16天前
已完结
The present and future of bispecific antibodies for cancer therapy
19天前
已完结
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study
3个月前
已完结
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
3个月前
已完结
A practical approach to the modern diagnosis and classification of T-and NK-cell lymphomas
4个月前
已完结
A practical approach to the modern diagnosis and classification of T-and NK-cell lymphomas
4个月前
已关闭
A practical approach to the modern diagnosis and classification of T-and NK-cell lymphomas
4个月前
已关闭
A practical approach to the modern diagnosis and classification of T-and NK-cell lymphomas
4个月前
已关闭
皖公网安备34019202002308
